Review

Rev Diabet Stud, 2007, 4(1):13-24 DOI 10.1900/RDS.2007.4.13

Genes, Diet and Type 2 Diabetes Mellitus: A Review

George V.Z. Dedoussis, Andriana C. Kaliora, Demosthenes B. Panagiotakos

Department of Nutrition and Dietetics, Harokopio University of Athens, 70 El. Venizelou Str., 17671 Kallithea-Athens, Greece.
Address correspondence to: George Dedoussis, e-mail: dedousi@hua.gr

Keywords: diabetes, diet, genes, polymorphism, gene-diet interaction

Abstract

Diabetes mellitus is widely recognized as one of the leading causes of death and disability. While insulin insensitivity is an early phenomenon partly related to obesity, pancreatic β-cell function declines gradually over time even before the onset of clinical hyperglycemia. Several mechanisms have been proposed to be responsible for insulin resistance, including increased non-esterified fatty acids, inflammatory cytokines, adipokines, and mitochondrial dysfunction, as well as glucotoxicity, lipotoxicity, and amyloid formation for β-cell dysfunction. Moreover, the disease has a strong genetic component, although only a handful of genes have been identified so far. Diabetic management includes diet, exercise and combinations of antihyperglycemic drug treatment with lipid-lowering, antihypertensive, and antiplatelet therapy. Since many persons with type 2 diabetes are insulin resistant and overweight, nutrition therapy often begins with lifestyle strategies to reduce energy intake and increase energy expenditure through physical activity. These strategies should be implemented as soon as diabetes or impaired glucose homoeostasis (pre-diabetes) is diagnosed.

Fulltext: HTML , PDF (376KB)


This article has been cited by other articles:

Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus

Xu DY, Zhao SP, Huang QX, Du W, Liu YH, Liu L, Xie XM

Diabetes Res Clin Pract 2010. 88(1):71-75

Evidence of interaction between type 2 diabetes susceptibility genes and dietary fat intake for adiposity and glucose homeostasis-related phenotypes

Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T, Bouchard C, Perusse L

J Nutrigenet Nutrigenomics 2009. 2(4-5):225-234

Obesity and cardiovascular disease: From pathophysiology to risk stratification

Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Stefanadis C

Int J Cardiol 2009. Apr 25, epub ahead of print

Type 2 diabetes, multifactorial heredity and primary prevention

Bassan N, Vinuesa M, Soldano O, Sciarresi E, Bruera G, Di Sipio A, Venecia S

Acta Cient Estud 2008. 6(4):168-178

A genetic contribution to circulating cytokines and obesity in children

Cai G, Cole SA, Butte NF, Smith CW, Mehta NR, Voruganti VS, Proffitt JM, Comuzzie AG

Cytokine 2008. 44(2):242-247

Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation

Stehr CB, Carvajal CA, Lacourt P, Alcaíno H, Mellado R, Cattani A, Mosso LM, Lavandera S, Fardella CE

Rev Med Chil 2008. 136(9):1134-1140

Age-dependent dichotomous effect of superoxide dismutase Ala16Val polymorphism on oxidized LDL levels

Dedoussis GV, Kanoni S, Panagiotakos DB, Louizou E, Grigoriou E, Chrysohoou C, Pitsavos C, Stefanadis C

Exp Mol Med 2008. 40(1):27-34

Impact of Metabolic Syndrome Risk Factors in First-Degree Relatives of Type 2 Diabetic Patients

Siewert S, Filipuzzi S, Codazzi L, Gonzalez I, Ojeda MS

Rev Diabet Stud 2007. 4(3):177-184

Genomics of Common Diseases

Revill P

Drug News Perspect 2007. 20(7):475-479